Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Muscle fatigue
ADR ID BADD_A04846
ADR Hierarchy
15      Musculoskeletal and connective tissue disorders
15.05      Muscle disorders
15.05.03      Muscle related signs and symptoms NEC
15.05.03.006      Muscle fatigue
Description A state arrived at through prolonged and strong contraction of a muscle. Studies in athletes during prolonged submaximal exercise have shown that muscle fatigue increases in almost direct proportion to the rate of muscle glycogen depletion. Muscle fatigue in short-term maximal exercise is associated with oxygen lack and an increased level of blood and muscle lactic acid, and an accompanying increase in hydrogen-ion concentration in the exercised muscle. [MeSH]
MedDRA Code 10049565
MeSH ID D018763
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Muscle fatigue | Muscle Fatigue | Muscular Fatigue | Fatigue, Muscular | Fatigue, Muscle
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00014Abiraterone0.001471%
BADD_D00121Amlodipine0.000031%
BADD_D00156Apremilast0.002316%
BADD_D00182Atorvastatin calcium--
BADD_D00183Atorvastatin calcium propylene glycol--
BADD_D00184Atorvastatin calcium trihydrate--
BADD_D00209Baclofen0.000505%
BADD_D00356Carbamazepine0.000842%
BADD_D00504Clopidogrel0.000026%
BADD_D00574Dalfampridine0.002614%
BADD_D00589Dasatinib0.000799%
BADD_D00680Dimethyl fumarate0.002751%
BADD_D00765Empagliflozin0.000749%
BADD_D00802Ertapenem0.000213%
BADD_D01253Lenalidomide0.003474%
BADD_D01275Levofloxacin0.000693%
BADD_D01285Levothyroxine0.000069%
BADD_D01654Palbociclib0.000533%
BADD_D01656Paliperidone0.006260%
BADD_D01798Pomalidomide0.001158%
BADD_D01922Regorafenib0.000799%
BADD_D01927Reslizumab--
BADD_D01954Rivaroxaban--
BADD_D01971Rosuvastatin0.000088%
BADD_D01978Ruxolitinib0.000533%
BADD_D02010Sertraline0.000016%
BADD_D02026Simvastatin0.000031%
BADD_D02031Sitaxentan--
BADD_D02047Sodium oxybate0.001817%
BADD_D02058Sorafenib0.000799%
The 1th Page    1 2    Next   Last    Total 2 Pages